𝗥𝗲𝘁𝗵𝗶𝗻𝗸𝗶𝗻𝗴 𝗙𝗼𝗼𝗱 𝗧𝗵𝗿𝗼𝘂𝗴𝗵 𝘁𝗵𝗲 𝗔𝘀𝗶𝗮𝗻 𝗚𝘂𝘁 𝗠𝗶𝗰𝗿𝗼𝗯𝗶𝗼𝗺𝗲 What if your body’s response to char kway teow isn’t just about calories—but timing, composition, and your gut microbiome? A recent Straits Times feature (https://lnkd.in/ghSP-T-2) highlights how diet timing and gut health go hand-in-hand. We’re advancing this research through 𝘁𝗵𝗲 𝗥𝗘𝗠𝗘𝗗𝗬 𝗽𝗿𝗼𝗴𝗿𝗮𝗺𝗺𝗲, led by A*STAR Singapore Institute of Food and Biotechnology Innovation (SIFBI) in partnership with precision gut microbiome company 𝗔𝗠𝗜𝗟𝗜. Together, we’re uncovering how Asian diets interact with the microbiome to influence health outcomes—insights that could pave the way for regionally tailored functional foods, preventive care, and healthier longevity. 🔗 Be part of the study shaping the future of food and health in Asia: https://lnkd.in/g23W3h_s #MicrobiomeResearch #EnhancingLives #ASTARResearch
A*STAR - Agency for Science, Technology and Research
Research Services
Creating Growth, Enhancing Lives
About us
About the Agency for Science, Technology and Research (A*STAR) The Agency for Science, Technology and Research (A*STAR) is Singapore's lead public sector agency that spearheads economic oriented research to advance scientific discovery and develop innovative technology. Through open innovation, we collaborate with our partners in both the public and private sectors to benefit society. As a Science and Technology Organisation, A*STAR bridges the gap between academia and industry. Our research creates economic growth and jobs for Singapore, and enhances lives by contributing to societal benefits such as improving outcomes in healthcare, urban living, and sustainability. We play a key role in nurturing and developing a diversity of talent and leaders in our Agency and research entities, the wider research community and industry. A*STAR’s R&D activities span biomedical sciences and physical sciences and engineering, with research entities primarily located in Biopolis and Fusionopolis. For ongoing news, visit www.a-star.edu.sg.
- Website
-
http://www.a-star.edu.sg/
External link for A*STAR - Agency for Science, Technology and Research
- Industry
- Research Services
- Company size
- 5,001-10,000 employees
- Headquarters
- Singapore
- Type
- Government Agency
- Specialties
- Research & Development, Science and Engineering, and Biomedical Sciences
Locations
-
Primary
Get directions
#20-10 Connexis North
Singapore, 138632, SG
Employees at A*STAR - Agency for Science, Technology and Research
Updates
-
𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗚𝗹𝗼𝗯𝗮𝗹 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗜𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝘂𝘀 𝗗𝗶𝘀𝗲𝗮𝘀𝗲𝘀 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗮𝗻𝗱 𝗤𝘂𝗮𝗻𝘁𝘂𝗺 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 A*STAR is expanding its research collaborations with two of France’s leading institutions—deepening partnerships in infectious diseases research and quantum technologies. These agreements were spotlighted during Deputy Prime Minister Heng Swee Keat’s working visit to France this week: 🔹 A*STAR Infectious Diseases Labs - A*STAR IDL and Institut Pasteur, formalising a Master Research Collaboration Agreement that will initiate two joint research projects on 𝘈𝘨𝘦𝘪𝘯𝘨 𝘢𝘯𝘥 𝘐𝘯𝘧𝘦𝘤𝘵𝘪𝘰𝘯 and 𝘔𝘪𝘤𝘳𝘰𝘣𝘪𝘰𝘮𝘦 𝘢𝘯𝘥 𝘐𝘯𝘧𝘦𝘤𝘵𝘪𝘰𝘯 🔹 Singapore’s National Quantum Office (NQO) and France’s Centre National de la Recherche Scientifique (CNRS): advancing joint efforts in quantum energetics and photonics. The MRCA between A*STAR IDL and Institut Pasteur will support research into how infections influence ageing and microbial balance—areas critical to understanding chronic disease progression, strengthening immune health, and improving resilience against future health threats. The collaboration also facilitates talent exchange and opens pathways to international grant opportunities, further strengthening long-term research ties. In the quantum space, NQO, a national platform hosted by A*STAR, and CNRS will focus on joint research in quantum energetics and leverage each country’s complementary strengths in photonic device development. These partnerships reflect A*STAR’s commitment to working with global institutions to address shared challenges and deliver science and technology outcomes with real-world impact. 🔗 Learn more about A*STAR IDL’s role in strengthening health resilience and enhancing pandemic preparedness: https://lnkd.in/gGgvbNPZ 🔗 Learn more about A*STAR’s role advancing quantum technologies: https://lnkd.in/gjquJ44V Lisa F.P. Ng, Yasmine Belkaid, Keok Tong Ling, Alain Schuhl, National Research Foundation Singapore, Ministry of Foreign Affairs (MFA) Singapore #InnovatewithASTAR #CreatingGrowth #EnhancingLives #SGFrance #Collaboration #InfectiousDiseases #QuantumTechnologies #Innovation #HealthResilience
Good meeting French Minister in charge of Higher Education and Research Philippe Baptiste yesterday. We had a fruitful discussion on enhancing bilateral collaboration to further our interests in science and research. We also witnessed the exchange of two signed agreements which mark a new chapter in the expanding collaborations between Singapore and France’s research institutions: ✅ A*STAR Infectious Diseases Labs (A*STAR IDL) and Institut Pasteur formalised a Master Research Collaboration Agreement, that will initiate two joint research projects on how infections impact ageing and microbial balance — areas critical to understanding chronic disease progression, strengthening immune health, and improving resilience against future health threats; ✅ Singapore’s National Quantum Office (NQO) and France’s Centre National de la Recherche Scientifique (CNRS) signed an MOU to advance joint efforts in quantum energetics and the development of photonic devices. These collaborations not only deepen our ongoing partnerships with France in infectious diseases research and quantum technologies, but also reflect our shared commitment to harnessing science for greater good, and open pathways to more opportunities and knowledge exchange. Congratulations to A*STAR - Agency for Science, Technology and Research and NQO on this important milestone! I look forward to seeing these collaborations help address common challenges, and contribute to meaningful advancement in science and technology in the years to come.
-
-
𝗔*𝗦𝗧𝗔𝗥 𝗜𝗠𝗖𝗕 𝗮𝘁 𝟰𝟬: 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗦𝗶𝗻𝗴𝗮𝗽𝗼𝗿𝗲’𝘀 𝗕𝗶𝗼𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗙𝘂𝘁𝘂𝗿𝗲 From humble beginnings to a global biomedical force, this year A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) celebrates 40 years of scientific discovery, innovation, and impact. Founded in 1985 as Singapore’s first biomedical research institute, A*STAR IMCB has been at the forefront of scientific discovery — helping transform Singapore from a “nation of technicians” to a biomedical innovation hub. Landmark contributions include: ✨ Pioneering discoveries in protein kinases and phosphatases — commemorated on Singapore’s $10,000 note [Monetary Authority of Singapore (MAS)] ✨ Sequencing the Fugu fish genome – a breakthrough that helped scientists better understand the human genome and uncover disease-related genes ✨ Catalysing biotech innovation through spin-offs like Albatroz Therapeutics, BioCheetah Pte Ltd, Sunbird Bio, and Intra-ImmuSG Beyond the lab A*STAR IMCB has shaped the next generation of scientific leaders, training over 400 PhD students and more than 1,000 postdoctoral fellows. To our researchers, alumni, and partners — thank you for being part of this extraordinary journey. Here’s to the next era of discovery and innovation. 🔗Explore IMCB’s legacy and ongoing work: https://lnkd.in/g6Zvn3bJ #IMCB40 #ASTARforIndustry #ScienceForImpact #InnovationSG
Minister for Manpower and Second Minister for Trade and Industry Published by and at the direction of Tan See Leng. Blk 46 Marine Crescent #01- 42 Singapore 440046
I joined the A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) to celebrate their 40th Anniversary Gala Dinner last evening. As Singapore’s first life sciences research institute, IMCB has played a pivotal role in our biomedical journey as we grew to become a key node in the global biomedical value chain. In today’s uncertain and complex global environment, it is even more important for us to strengthen Singapore’s value proposition. A core part of this lies in building deep research and technological capabilities. A*STAR, including IMCB, will have a vital role to play in this effort. As IMCB charts its course forward, they will focus on emerging biomedical areas for impact while nurturing a vibrant scientific pool. To this end, I am glad to witness the launch of the IMCB Alumni Chapter — an important step in bringing together IMCB’s scientific community to collaborate, grow, and inspire the next generation. Congratulations IMCB on 40 remarkable years. Here's to many more decades of scientific excellence and innovation!
-
-
𝗔 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗦𝘁𝗿𝗶𝗸𝗲 𝗔𝗴𝗮𝗶𝗻𝘀𝘁 𝗖𝗮𝗻𝗰𝗲𝗿🎯 Engine Biosciences and Singapore’s Experimental Drug Development Centre (EDDC), are joining forces to develop precision therapeutics for common cancers like breast, liver, kidney and prostate cancer. Their target: ENB-871, a cancer-linked protein. By identifying biomarkers that indicate which patients are most likely to benefit, the goal is to develop novel compounds that directly target and eliminate this protein. This partnership combines Engine’s AI-driven platform with EDDC’s drug development expertise, accelerating the path towards smarter, more personalised cancer treatments. We’re excited to support this journey and see the impact of this collaboration take shape. Read more 👉 https://lnkd.in/gTH-tgzW Learn more about EDDC 👉 https://www.eddc.sg/ Damian O'Connell Jeffrey Lu #InnovatewithASTAR #ASTARforSG #CreatingGrowth #Biotech #Medtech
We’re thrilled to announce our partnership with Engine Biosciences to advance the development of first-in-class precision cancer therapeutics. This collaboration unites Engine’s AI-driven NetMAPPR platform with EDDC’s drug discovery and development expertise around a first project where the parties will jointly develop small molecule degraders to address “ENB-871” - a novel pairing of a drug target and patient selection biomarkers discovered through Engine’s platform. Our CEO Damian O'Connell shared regarding this collaboration, “The future of drug development lies in precision-driven innovation. Our partnership with Engine enables us to develop therapies tailored to specific patient populations through Engine’s biomarker-driven patient selection approaches. We are particularly excited to launch our first collaborative project around monovalent small molecule degraders, building on EDDC’s expanding capabilities in this field. Beyond this, we look forward to strengthening our partnership by advancing more precision therapies that have the potential to transform the lives of cancer patients in need.” We look forward to working with Engine Biosciences, moving towards more effective, safer, and tailored cancer treatments together. Read the full press release here: https://lnkd.in/gTH-tgzW #EDDCsg #EngineBiosciences #Collaboration #Partnership #DrugDiscovery #PrecisionMedicine #CancerResearch
-
-
Doubling Down on Safer, Smarter Energy Storage Batteries in phones and EVs rely on liquid electrolytes to move lithium ions—yet these liquids can leak or ignite when overheated. At A*STAR Institute of Materials Research and Engineering (A*STAR IMRE), Derrick Fam, Deputy Head of the Energy Materials Department and his team are developing solid-state electrolytes (SSEs) as a safer, more efficient alternative, by: - Tackling sluggish ion flow in polymers - Overcoming cathode crystallisation - Doubling down on room-temp performance With tailored polymers, deep materials science, and precision engineering, the team combats safety risks, rejuvenates battery performance, and clears the way for next-gen energy resilience. 🔗 Learn more: https://lnkd.in/gJqUzcgN #InnovateWithASTAR #CreatingGrowth #SolidStateBatteries #EnergyResilience #BatteryInnovation
-
-
Shaping the Future of Maritime Innovation At Singapore Maritime Week (SMW) 2025, A*STAR showcased cutting-edge solutions to enhance vessel performance, safety, and supply chain resilience. Strengthening our commitment to maritime innovation, Institute of High Performance Computing (A*STAR IHPC) is driving sustainability and resilience in shipping with industry partners. These partnerships will advance initiatives such as the Wind-Assisted Propulsion System (WAPS) Programme, which explores wind propulsion as a zero-emission alternative to reduce fuel consumption and greenhouse gas emissions. We’re also deepening our work in geospatial technologies with Maritime and Port Authority of Singapore (MPA) and partners to improve real-time monitoring and smarter decision-making in maritime operations. Our researchers also joined critical conversations shaping the industry’s future. Dr Yi Su, Executive Director of A*STAR IHPC, shared how wind propulsion can support sustainable shipping. Dr Xiuju Fu, Director of A*STAR’s Maritime AI Research Programme, spoke on the potential of Digital Twin technologies in boosting efficiency, safety, and climate resilience. 🔗 If you're in the maritime space and looking to collaborate on next-gen solutions, let’s connect: https://lnkd.in/gcHdn7YN #InnovateWithASTAR #CreatingGrowth #SMW2025 Photos by Maritime and Port Authority of Singapore
-
-
-
-
-
+1
-
-
A*STAR researchers teleport kaya toast Our researchers have finally done it: teleporting a kaya toast sandwich a full 0.002mm. Still warm. Crust slightly misaligned. A small step for breakfast, but a light-hearted nod to the kind of deep tech we’re truly working on across advanced communications, photonics and frontier computing. While full-scale teleportation remains April Fool’s territory, the science behind it—like quantum entanglement—is very real, and so is our work in it. If you're exploring partnerships in next-gen tech, reach out. We’re always open to bold ideas here: for.edu.sg/astar-qinc #CreatingGrowth #InnovateWithASTAR #AprilFools #QuantumTechnology
-
-
Selamat Hari Raya to all our Muslim colleagues and partners. May this festive season bring you joy, peace, and prosperity, and may your celebrations be filled with love and warmth. 🌙✨ #ASTARWishesYou #HariRaya2025
-
𝗜𝗻𝘀𝗽𝗶𝗿𝗶𝗻𝗴 𝗜𝗻𝗰𝗹𝘂𝘀𝗶𝗼𝗻 𝗔𝗺𝗼𝗻𝗴 𝗪𝗼𝗺𝗲𝗻 𝗶𝗻 𝗦𝗧𝗘𝗠 & 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 “𝘛𝘩𝘦 𝘤𝘩𝘢𝘭𝘭𝘦𝘯𝘨𝘦 𝘰𝘧 𝘴𝘤𝘪𝘦𝘯𝘤𝘦 𝘪𝘴 𝘭𝘪𝘬𝘦 𝘤𝘭𝘪𝘮𝘣𝘪𝘯𝘨 𝘔𝘰𝘶𝘯𝘵 𝘌𝘷𝘦𝘳𝘦𝘴𝘵.”- Professor Ada Yonath, Nobel Prize Winner for Chemistry, 2009 At the International Women in STEM & Medicine Symposium (IWSMS) 2025, A*STAR Chairman Professor Tan Chorh Chuan highlighted the importance of supporting women in reaching the summit of their careers. He highlighted several key actions to help make this possible: ✅ Creating inclusive workplaces ✅ Enhancing caregiving support ✅ Investing in mentorship & leadership pathways 👩🔬 Held in celebration of International Women’s Day, the symposium gathered leaders from industry, academia, and research to drive meaningful discussions on gender diversity and equity in STEM. A*STAR experts as well as industry and academia peers shared strategies to empower women in research and leadership. Let’s work together to build a more inclusive future in STEM. Read more about our #WomeninScience: for.edu.sg/astar-wis A*STAR’s Diversity Working Group (DWG) is proud to co-organise the event alongside Duke-NUS Medical School, National University of Singapore, National University Hospital, and HTX (Home Team Science & Technology Agency), SingHealth, United Women Singapore, Singapore Women in Science (SgWIS), Women@NTU, Women in Science Research Scientists Initiative (WinS-RSI), FemTech Association Asia #FacesofASTAR #OneASTAR #WomenInScience #IWD2024 #InspireInclusion #Diversity
-
-
#𝗜𝗖𝗬𝗠𝗜: 𝗦𝗶𝗻𝗴𝗮𝗽𝗼𝗿𝗲’𝘀 𝗻𝗲𝘄 𝗡𝗦𝗧𝗜𝗖 𝗥&𝗗 𝗙𝗮𝗯 𝗶𝘀 𝗮𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗶𝗻𝗴 𝘀𝗲𝗺𝗶𝗰𝗼𝗻𝗱𝘂𝗰𝘁𝗼𝗿 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻—𝗳𝗿𝗼𝗺 𝗹𝗮𝗯 𝘁𝗼 𝗳𝗮𝗯. With its initial focus on advanced packaging technologies, the National Semiconductor Translation and Innovation Centre (NSTIC R&D Fab) is set to enhance chip performance and efficiency, and drive breakthroughs in semiconductor research and commercialisation. This national platform offers industry-grade cleanroom access—empowering companies and researchers to co-develop innovations, scale up technologies, and train the next generation of semiconductor talent. This investment strengthens Singapore’s role in the global semiconductor supply chain, unlocking new opportunities for industry growth and technological advancements. A*STAR is proud to be part of this journey—enabling collaborations, pushing the frontiers of research, and shaping the future of semiconductors. Interested a career in semiconductors? Check out the latest openings here: for.edu.sg/astar-careers #InnovateWithASTAR #CreatingGrowth #Semiconductors #Innovation
Deputy Prime Minister, Minister for Trade & Industry and Chairman of the Monetary Authority of Singapore, Republic of Singapore. Published by & at the direction of Gan Kim Yong.
Singapore is a critical node in the global semiconductor supply chain, and continued R&D investment to drive innovation is key to staying ahead. I recently visited the National Semiconductor Translation and Innovation Centre (NSTIC) at Fusionopolis, an initiative by A*STAR - Agency for Science, Technology and Research which has been driving collaborations between researchers and industry in flat optics and silicon photonics since its launch last year. To further strengthen our semiconductor industry, I announced at the Ministry of Trade and Industry (Singapore)’s Committee of Supply (COS) Debate that we are committing $500 million to establish the NSTIC (R&D Fab), a new national semiconductor R&D fabrication facility at JTC Corporation nanoSpace @ Tampines. With an initial focus on advanced packaging, this new facility will serve as a collaborative hub where public and private sectors share access to state-of-the-art semiconductor R&D infrastructure to bridge the gap for lab-to-fab semiconductor R&D translation. This will be particularly beneficial to SMEs and startups, as it provides them with access to critical semiconductor infrastructure which will otherwise require substantial upfront investments. Major global semiconductor players as well as SMEs and startups can tap on NSTIC (R&D Fab)’s capabilities and foster new partnerships to accelerate technology development and scale innovations to market-ready solutions. As we enter the next phase of our economic growth, our investments in initiatives like NSTIC (R&D Fab) will enable us to sharpen our technological edge. This will create better opportunities for Singapore businesses and Singaporeans, keep our economy vibrant and resilient, and secure a better future for Singapore. Read my COS speech here: https://lnkd.in/gJ4EReyR
-